| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Absci Corp | Chief Innovation Officer | Common Stock | 258K | $284K | $1.10 | Feb 1, 2024 | Direct |
| Absci Corp | Chief Innovation Officer | Stock Option (right to buy) | 350K | Feb 1, 2024 | Direct | ||
| Cyclerion Therapeutics, Inc. | Chief Scientific Officer | Employee Stock Option (Right to Buy) | 135K | Jan 20, 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| ABSI | Absci Corp | Feb 1, 2024 | 2 | $0 | 4 | Feb 5, 2024 | Chief Innovation Officer |
| ABSI | Absci Corp | Oct 12, 2023 | 1 | $0 | 4 | Oct 16, 2023 | Chief Innovation Officer |
| ABSI | Absci Corp | Mar 1, 2023 | 1 | $0 | 4 | Mar 3, 2023 | Chief Innovation Officer |
| ABSI | Absci Corp | Oct 3, 2022 | 1 | $0 | 4 | Oct 5, 2022 | Chief Innovation Officer |
| ABSI | Absci Corp | Jun 8, 2022 | 1 | $0 | 4 | Jun 10, 2022 | Director |
| ABSI | Absci Corp | Mar 17, 2022 | 1 | $0 | 4 | Mar 21, 2022 | Director |
| ABSI | Absci Corp | Mar 17, 2022 | 0 | $0 | 3 | Mar 21, 2022 | Director |
| CYCN | Cyclerion Therapeutics, Inc. | Jan 20, 2022 | 1 | $0 | 4 | Jan 24, 2022 | Chief Scientific Officer |
| CYCN | Cyclerion Therapeutics, Inc. | Dec 9, 2021 | 1 | $0 | 4 | Dec 10, 2021 | Chief Scientific Officer |